{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:08:57Z","timestamp":1778202537539,"version":"3.51.4"},"reference-count":111,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272396"],"award-info":[{"award-number":["82272396"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.hbpd.2026.01.008","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:06:36Z","timestamp":1769713596000},"page":"134-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Organoid models in viral hepatitis, primary liver cancer, and non-alcoholic fatty liver disease: Advances and challenges"],"prefix":"10.1016","volume":"25","author":[{"given":"Ya-Qin","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Fang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Na","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2026.01.008_bib0001","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0002","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jmcb\/mjaa013","article-title":"Progress in human liver organoids","volume":"12","author":"Sun","year":"2020","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0003","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-019-0255-2","article-title":"Organoid models of gastrointestinal cancers in basic and translational research","volume":"17","author":"Lau","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0004","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1083\/jcb.201610056","article-title":"Organoids: a historical perspective of thinking in three dimensions","volume":"216","author":"Simian","year":"2017","journal-title":"J Cell Biol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0006","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/523520a","article-title":"The boom in mini stomachs, brains, breasts, kidneys and more","volume":"523","author":"Willyard","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.devcel.2010.01.011","article-title":"Organogenesis and development of the liver","volume":"18","author":"Si-Tayeb","year":"2010","journal-title":"Dev Cell"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0008","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.3390\/ijms24054529","article-title":"Liver organoids as an in vitro model to study primary liver cancer","volume":"24","author":"De Siervi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0009","doi-asserted-by":"crossref","first-page":"245sr2","DOI":"10.1126\/scitranslmed.3005975","article-title":"Cell and tissue engineering for liver disease","volume":"6","author":"Bhatia","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0010","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.hbpd.2023.03.010","article-title":"Radiomics in the diagnosis and treatment of hepatocellular carcinoma","volume":"22","author":"Jiang","year":"2023","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0011","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/hep4.1312","article-title":"Murine liver organoids as a genetically flexible system to study liver cancer in vivo and in vitro","volume":"3","author":"Saborowski","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0012","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","article-title":"Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids","volume":"30","author":"Ouchi","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0013","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.celrep.2018.07.001","article-title":"Organoid models of human liver cancers derived from tumor needle biopsies","volume":"24","author":"Nuciforo","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0014","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","article-title":"High-fidelity drug-induced liver injury screen using human pluripotent stem cell-derived organoids","volume":"160","author":"Shinozawa","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0015","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/hep.31772","article-title":"Hepatobiliary organoids and their applications for studies of liver health and disease: are we there yet?","volume":"74","author":"Shiota","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0016","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1242\/dev.079590","article-title":"In vitro organogenesis in three dimensions: self-organising stem cells","volume":"139","author":"Sasai","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0017","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1038\/s41467-021-23575-1","article-title":"Generation of functional liver organoids on combining hepatocytes and cholangiocytes with hepatobiliary connections ex vivo","volume":"12","author":"Tanimizu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0018","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.stem.2017.05.020","article-title":"Differentiation of human pluripotent stem cells into colonic organoids via transient activation of BMP signaling","volume":"21","author":"M\u00fanera","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0019","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ydbio.2017.11.018","article-title":"Timing is everything: reiterative Wnt, BMP and RA signaling regulate developmental competence during endoderm organogenesis","volume":"434","author":"Rankin","year":"2018","journal-title":"Dev Biol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0020","doi-asserted-by":"crossref","DOI":"10.1126\/science.1247125","article-title":"Organogenesis in a dish: modeling development and disease using organoid technologies","volume":"345","author":"Lancaster","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0021","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41578-020-0199-8","article-title":"Synthetic alternatives to Matrigel","volume":"5","author":"Aisenbrey","year":"2020","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0022","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/ncb3632","article-title":"Synthetic hydrogels for human intestinal organoid generation and colonic wound repair","volume":"19","author":"Cruz-Acu\u00f1a","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0023","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0024","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1021\/acsami.2c17467","article-title":"Recent advances in brain organoid technology for human brain research","volume":"15","author":"Jeong","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0025","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/s41596-021-00589-z","article-title":"Intestinal organoid cocultures with microbes","volume":"16","author":"Puschhof","year":"2021","journal-title":"Nat Protoc"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0026","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","article-title":"Progress and potential in organoid research","volume":"19","author":"Rossi","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.762184","article-title":"Patient-derived organoids in precision medicine: drug screening, organoid-on-a-chip and living organoid biobank","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100840","article-title":"Drug screening model meets cancer organoid technology","volume":"13","author":"Liu","year":"2020","journal-title":"Transl Oncol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0029","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molmed.2017.02.007","article-title":"Disease modeling in stem cell-derived 3D organoid systems","volume":"23","author":"Dutta","year":"2017","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0030","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nm.2695","article-title":"Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell","volume":"18","author":"Yui","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0031","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature11826","article-title":"In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration","volume":"494","author":"Huch","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0032","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.stem.2013.11.010","article-title":"Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells","volume":"14","author":"Taguchi","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0033","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0034","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.semnephrol.2020.01.009","article-title":"The utility of human kidney organoids in modeling kidney disease","volume":"40","author":"Przepiorski","year":"2020","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0035","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41563-020-00853-9","article-title":"Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation","volume":"20","author":"Lawlor","year":"2021","journal-title":"Nat Mater"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0036","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.stemcr.2022.08.013","article-title":"TGF\u03b2 superfamily signaling regulates the state of human stem cell pluripotency and capacity to create well-structured telencephalic organoids","volume":"17","author":"Watanabe","year":"2022","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0037","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s42003-023-04543-5","article-title":"Self-organization, quality control, and preclinical studies of human iPSC-derived retinal sheets for tissue-transplantation therapy","volume":"6","author":"Watari","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0038","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fcell.2019.00345","article-title":"Next-generation liver medicine using organoid models","volume":"7","author":"Akbari","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0039","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s13770-021-00357-w","article-title":"Liver organoids: formation strategies and biomedical applications","volume":"18","author":"Zhu","year":"2021","journal-title":"Tissue Eng Regen Med"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41578-018-0023-x","article-title":"Extracellular matrix-based materials for regenerative medicine","volume":"3","author":"Hussey","year":"2018","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0041","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jhep.2018.12.028","article-title":"Generation of hepatobiliary organoids from human induced pluripotent stem cells","volume":"70","author":"Wu","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0042","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12929-020-00661-y","article-title":"The endothelium, a key actor in organ development and hPSC-derived organoid vascularization","volume":"27","author":"Vargas-Valderrama","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0043","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature12271","article-title":"Vascularized and functional human liver from an iPSC-derived organ bud transplant","volume":"499","author":"Takebe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.844001","article-title":"The roles of mesenchymal stem cells in gastrointestinal cancers","volume":"13","author":"Xiang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0045","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/14787210.2018.1505503","article-title":"Global epidemiology of viral hepatitis and national needs for complete control","volume":"16","author":"Lanini","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0046","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3390\/microorganisms10112096","article-title":"Viral diagnosis of hepatitis B and delta: what we know and what is still required? Specific focus on low- and middle-income countries","volume":"10","author":"Ceesay","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0047","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2478\/jtim-2024-0015","article-title":"Role of viral hepatitis in pregnancy and its triggering mechanism","volume":"12","author":"Wu","year":"2024","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0048","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.51335\/organoid.2024.4.e11","article-title":"Three-dimensional liver organoids as a novel platform for studying hepatitis B virus infection","volume":"4","author":"Kim","year":"2024","journal-title":"Organoid"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0049","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jhep.2020.09.013","article-title":"A global investment framework for the elimination of hepatitis B","volume":"74","author":"Howell","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3748\/wjg.v28.i1.76","article-title":"Viral hepatitis in 2021: the challenges remaining and how we should tackle them","volume":"28","author":"Dunn","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0051","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41419-021-03924-0","article-title":"Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal hepatitis B viral genome in preclinical models","volume":"12","author":"Clark","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0052","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ebiom.2018.08.014","article-title":"Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells","volume":"35","author":"Nie","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0053","doi-asserted-by":"crossref","DOI":"10.1038\/srep29358","article-title":"Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus","volume":"6","author":"Kaneko","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0054","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2016.10.009","article-title":"Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions","volume":"66","author":"Xia","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0055","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210320","article-title":"Modelling T-cell immunity against hepatitis C virus with liver organoids in a microfluidic coculture system","volume":"12","author":"Natarajan","year":"2022","journal-title":"Open Biol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108859","article-title":"A genome-wide CRISPR screen identifies UFMylation and TRAMP-like complexes as host factors required for hepatitis A virus infection","volume":"34","author":"Kulsuptrakul","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0057","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jmv.27356","article-title":"Gut microbiota dysbiosis associated with plasma levels of interferon-\u03b3 and viral load in patients with acute hepatitis E infection","volume":"94","author":"Wu","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0058","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.hbpd.2024.12.007","article-title":"Serum exosome-derived ALDH1A1 can greatly predict the prognosis of patients with hepatitis E virus-related acute liver failure","volume":"24","author":"Shang","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0059","doi-asserted-by":"crossref","first-page":"eabj5908","DOI":"10.1126\/sciadv.abj5908","article-title":"Recapitulating hepatitis E virus-host interactions and facilitating antiviral drug discovery in human liver-derived organoids","volume":"8","author":"Li","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0060","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1158\/0008-5472.CAN-09-3950","article-title":"Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species","volume":"70","author":"Jin","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105228","article-title":"Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling","volume":"197","author":"Li","year":"2022","journal-title":"Antiviral Res"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0062","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3350\/cmh.2022.0428","article-title":"A decade of liver organoids: advances in disease modeling","volume":"29","author":"Liu","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0063","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60747","article-title":"Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma","volume":"10","author":"De Crignis","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0064","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2022.05.037","article-title":"Pathogenesis of primary liver carcinomas","volume":"78","author":"Paradis","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0065","article-title":"New insights into the pathophysiology and clinical care of rare primary liver cancers","volume":"3","author":"Gigante","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0066","article-title":"Immunotherapy of hepatocellular carcinoma: recent progress and new strategy","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0067","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.pathol.3.121806.154244","article-title":"Mouse models of cancer","volume":"6","author":"Cheon","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0068","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.hbpd.2023.12.004","article-title":"Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score","volume":"24","author":"Sun","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0069","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajpath.2013.10.028","article-title":"The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy","volume":"184","author":"Knudsen","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0070","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41556-019-0359-5","article-title":"Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes","volume":"21","author":"Sun","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0071","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s13402-022-00707-3","article-title":"Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer","volume":"45","author":"Xian","year":"2022","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0072","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121490","article-title":"Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity","volume":"4","author":"Li","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0073","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1158\/0008-5472.CAN-21-1017","article-title":"A combinatorial CRISPR-Cas9 screen identifies ifenprodil as an adjunct to sorafenib for liver cancer treatment","volume":"81","author":"Xu","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0074","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13046-022-02436-9","article-title":"Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors","volume":"41","author":"Lim","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.10.013","article-title":"Extracellular matrix component signaling in cancer","volume":"97","author":"Multhaupt","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0076","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcmgh.2020.09.003","article-title":"Cancer-associated fibroblasts provide a stromal niche for liver cancer organoids that confers trophic effects and therapy resistance","volume":"11","author":"Liu","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0077","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0078","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.634409","article-title":"Controversies and opportunities in the use of inflammatory markers for diagnosis or risk prediction in fatty liver disease","volume":"11","author":"Lambrecht","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0079","first-page":"76","article-title":"Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations","volume":"8","author":"Kumar","year":"2020","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0080","first-page":"216","article-title":"Non-alcoholic fatty liver disease in lean subjects: characteristics and implications","volume":"5","author":"Kumar","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0081","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0082","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0083","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jcmgh.2023.01.014","article-title":"Modeling nonalcoholic fatty liver disease in the dish using human-specific platforms: strategies and limitations","volume":"15","author":"Rezvani","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0084","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/hep.31857","article-title":"Functional characterization of organoids derived from irreversibly damaged liver of patients with NASH","volume":"74","author":"McCarron","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0085","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41587-023-01680-4","article-title":"Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis","volume":"41","author":"Hendriks","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0086","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1021\/acsbiomaterials.0c00682","article-title":"Modeling human nonalcoholic fatty liver disease (NAFLD) with an organoids-on-a-chip system","volume":"6","author":"Wang","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0087","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5812\/hepatmon.6128","article-title":"Dual role of miR-122 in molecular pathogenesis of viral hepatitis","volume":"12","author":"Sendi","year":"2012","journal-title":"Hepat Mon"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0088","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","article-title":"miR-122\u2013a key factor and therapeutic target in liver disease","volume":"62","author":"Bandiera","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0089","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1566523214666141224095610","article-title":"miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir","volume":"15","author":"Thakral","year":"2015","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200847","article-title":"miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling","volume":"13","author":"Sendi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0091","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.bbalip.2018.06.018","article-title":"The role of PNPLA3 in health and disease","volume":"1864","author":"Pingitore","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0092","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"Kumari","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0093","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/hep.26170","article-title":"Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats","volume":"57","author":"Kumashiro","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0094","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molmet.2019.01.013","article-title":"Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice","volume":"22","author":"Lind\u00e9n","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0095","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/5744974","article-title":"Metabolic profiling and early diagnosis of alcoholic fatty liver disease using support vector machine model","volume":"2024","author":"You","year":"2024","journal-title":"Adv Gut Microbiome Res"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0096","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/ijms20071629","article-title":"Human multilineage 3D spheroids as a model of liver steatosis and fibrosis","volume":"20","author":"Pingitore","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0097","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","article-title":"The interaction between signal regulatory protein alpha (SIRP\u03b1) and CD47: structure, function, and therapeutic target","volume":"32","author":"Barclay","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0098","doi-asserted-by":"crossref","first-page":"F1117","DOI":"10.1152\/ajprenal.00359.2012","article-title":"Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management","volume":"303","author":"Rogers","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0099","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.matbio.2009.01.002","article-title":"Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress","volume":"28","author":"Isenberg","year":"2009","journal-title":"Matrix Biol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0100","doi-asserted-by":"crossref","first-page":"E1194","DOI":"10.1152\/ajpendo.00273.2018","article-title":"Myeloid-specific deletion of thrombospondin 1 protects against inflammation and insulin resistance in long-term diet-induced obese male mice","volume":"315","author":"Memetimin","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0101","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1038\/srep08846","article-title":"CD47 deficiency protects mice from diet-induced obesity and improves whole body glucose tolerance and insulin sensitivity","volume":"5","author":"Maimaitiyiming","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0102","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/liv.15182","article-title":"Anti-CD47 antibody treatment attenuates liver inflammation and fibrosis in experimental non-alcoholic steatohepatitis models","volume":"42","author":"Gwag","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0103","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41575-019-0181-3","article-title":"Organoid modelling of NAFLD","volume":"16","author":"Thomas","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0104","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0105","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajpath.2014.10.027","article-title":"Functional role of cellular senescence in biliary injury","volume":"185","author":"Meng","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0106","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/labinvest.2014.94","article-title":"Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis","volume":"94","author":"Tabibian","year":"2014","journal-title":"Lab Invest"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0107","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hep4.1809","article-title":"Induced pluripotent stem cells from subjects with primary sclerosing cholangitis develop a senescence phenotype following biliary differentiation","volume":"6","author":"Jalan-Sakrikar","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0108","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0109","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2013.03.007","article-title":"Global burden of alcoholic liver diseases","volume":"59","author":"Rehm","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hbpd.2026.01.008_bib0111","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41422-019-0242-8","article-title":"Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S149938722600010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S149938722600010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:06:44Z","timestamp":1776193604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S149938722600010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":111,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S149938722600010X"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2026.01.008","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organoid models in viral hepatitis, primary liver cancer, and non-alcoholic fatty liver disease: Advances and challenges","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2026.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}